FluMist®: Clinical Trials

8 trials of FluMist®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 1 unknown. 6 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 46Completed 4, Terminated 2
Phase 11Completed 1

Follow FluMist®: new trials by email Literature Review of FluMist® trials Research Report on FluMist®

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)
Fluzone®, FluMist® - Influenza
Phase 4TerminatedStanford University32015-09-012017-05-10
Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)
Fluzone®, FluMist® - Influenza
Phase 4TerminatedStanford University102014-11-192017-09-12
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
Fluzone®, FluMist® - Influenza, Healthy
Phase 1CompletedStanford University802014-09-302020-02-13
Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)
Fluzone®, FluMist® - Influenza
Phase 4CompletedStanford University772014-09-172018-12-14
LAIV (Flumist®) Administration in CF Patients
Flumist® - Cystic Fibrosis
UnknownMcGill University Health Centre/Research Institute of the McGill University Health Centre1702013-08-012014-09-16
The Human Mucosal Immune Responses to Influenza Virus (SLVP026)
Fluzone®, FluMist® - Influenza
Phase 4CompletedStanford University132012-12-012017-04-21
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012
TIV, High-Dose TIV, LAIV - Influenza
Phase 4CompletedStanford University222012-10-012017-05-22
Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)
FluMist® - Influenza
Phase 4CompletedStanford University182012-10-012021-10-18

Conditions studied

Influenza, Human (8)  ·  Cystic Fibrosis (1)

Sponsors

Stanford University (7)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Cornelia Dekker, MD (6)  ·  Harry Greenberg, MD (3)  ·  Mark Davis, PhD (3)  ·  Xiaosong He, PhD (3)  ·  Ann Arvin, MD (1)  ·  Caroline Quach-Thanh, MD, MSc (1)  ·  Cornelia L Dekker, MD (1)  ·  Garry Nolan, PhD (1)  ·  K. Christopher Garcia, PhD (1)  ·  Mark M Davis, PhD (1)  ·  Philip M Grant, MD (1)  ·  Stephen Quake, PhD (1)

NIH funding

U19AI057229 (6), U19AI090019 (1)